IL-1: interleukin 1; MHC: major histocompatibility complex; PECAM-1: platelet endothelial cell adhesion
PECAM-1 was investigated in renal biopsies from patients with primary renal diseases (n=66) and from Infiltration of the renal parenchyma with inflammatory renal allograft recipients (n=42).
cells, including lymphocytes, monocytes, and granuloMethods. Expression of the cell adhesion molecules cytes characterizes the histological picture of inflamwas determined by immunohistochemistry of frozen matory kidney diseases, autoimmune disorders and sections using monoclonal antibodies directed against renal allograft rejection [1,2]. PECAM-1, ICAM-1, VCAM-1, E-selectin and MHC
In the earliest stages of inflammatory processes, class II molecules (APAAP method).
leukocytes interact with the endothelial cell lining of Results and Conclusions. PECAM-1 and ICAM-1 were the vasculature [3 ] . Endothelial cell injury promotes expressed in the renal vasculature and disappeared in endothelial cell-leukocyte interaction that is mediated obliterated glomeruli with endothelial cell destruction.
by cell surface adhesion molecules to support leukocyte ICAM-1 but not PECAM-1 was upregulated in renal adhesion and transmigration [4] . E-selectin, which endothelia in acute allograft rejection and inflammatbelongs to the selectin family, turns up very early in ory primary renal diseases. Tubular de novo expression the inflammatory process. It binds to sialylated glycoof ICAM-1 and VCAM-1 correlated with severe strucproteins on leukocytes to promote the weak attraction tural damage of the renal parenchyma including interand rolling of leukocytes on endothelial cells [5 ] . The stitial fibrosis. Vascular and/or glomerular VCAM-1 immunoglobulin-like molecules ICAM-1 and VCAM-1 and E-selectin expression was pronounced in severe are responsible for the firm secondary endothelial acute allograft rejection and also reflected the intensity cell-leukocyte adhesion followed by transmigration of inflammatory reactions in primary renal diseases of leukocytes through the endothelial cell lining [6 ] . with or without autoimmune disorders. De novo expres-ICAM-1, which binds to the b2-integrins LFA-1 and sion of VCAM-1 and E-selectin in renal vessels and/or Mac-1 on leukocytes is expressed constitutively on glomeruli and overexpression of ICAM-1 are markers endothelial cells and leukocytes and upregulated by of acute and severe inflammatory processes in biopsies cytokines, such as IL-1 and TNFa [7] . VCAM-1 from allograft recipients and patients with primary expression is induced by cytokines on activated endorenal diseases.
thelial cells and some epithelial cells and binds to the b1-integrin VLA-4 [8 ]. Furthermore, ICAM-1 and Key words: E-selectin; ICAM-1; inflammatory kidney VCAM-1 support T-cell activation by acting as costidisease; PECAM-1; transplantation; VCAM-1; mulatory signals on target cells [9] . The role of Abbreviations: ANCA: anti-neutrophil cytoplasmic PECAM-1 in leukocyte-endothelial cell interaction antibody; APAAP: alkaline-phosphatase anti-alkaline
is not yet completely understood. It binds to itself or phosphatase; E-selectin: endothelial selectin; ICAM-1:
to the avb3-integrin and is expressed on many endointercellular adhesion molecule-1; IFNc: interferon c; thelial cell types as well as on monocytes and platelets [10] .
severe nephrotic syndrome, who were already under therapy VCAM-1, E-selectin and PECAM-1 in renal endowith steroids, cyclophosphamide or cyclosporin A.
thelial and epithelial cells in inflammatory kidney diseases and diÂerent forms of transplant rejection. To that end, the histopathological picture of inflammatory Monoclonal antibodies and non-inflammatory renal diseases and transplant rejection was correlated with the expression patterns The following mouse monoclonal antibodies were used for the detection of adhesion molecules in frozen sections of of adhesion molecules.
kidney biopsies: anti-human ICAM-1 (Clone BBIG-I1), antihuman VCAM-1 (BBIG-V1) and anti-human E-selectin (BBIG-E4), were obtained from H. Biermann AG, Bad
Subjects and methods
Nauheim, Germany; anti-human PECAM-1 (JC/70A) was from DAKO Diagnostika, Hamburg, Germany and anti-
Patients
human MHC class II (B8.12.2) from Immunotech, Hamburg, Germany. Mouse IgG was used as a negative control (Sigma, One hundred and eight renal biopsies were investigated; 66 Deisenhofen, Germany). Alkaline phosphatase-labelled goat were collected from patients with unclear primary renal anti-mouse secondary antibody, the APAAP detection system disease and 42 from allograft recipients. The biopsies of five and the New Fuchsin substrate system were obtained patients with unclear primary renal disease had only minimal from DAKO Diagnostika (Hamburg, Germany). All other glomerular changes and were therefore selected as 'normal' reagents were of the highest analytical grade available. renal tissue. In addition, five tissue samples from the diseasefree part of tumour nephrectomies were investigated. The group of patients biopsied because of unclear primary renal Immunohistochemistry disease comprised 27 women and 39 men with a mean age of 49 years. The distribution of histopathological diagnoses Tissue from renal biopsies was divided into two parts. One portion was fixed with 4% paraformaldehyde in PBS (phosof this group is listed in Table 1 . The group of patients with renal allografts consisted of 22 female and 20 male patients phate-buÂered saline) and paraÃn-embedded for diagnostic evaluation. The other portion was snap-frozen in liquidwith a mean age of 46 years with diÂerent forms of allograft rejection (11 with minimally aggressive rejection, 16 with nitrogen-cooled isopentane and stored at −70°C until use.
Immunohistochemistry was carried out on 5 mm cryostat moderately and severely aggressive rejection, and six with chronic rejection), acute tubular necrosis (n=5), and de novo sections which were dried overnight at 37°C and stored at −20°C. Sections were fixed with acetone for 20 min at or recurrent glomerulonephritis in their transplants (n=4 ). Allograft recipients were treated with a standard immuno-−20°C. After washing with PBS, sections were incubated for 2 h with mouse monoclonal antibodies directed against suppressive therapy of steroids and cyclosporin A with or without azathioprine. Antilymphocyte antibody therapy was ICAM-1 ( 158,000), VCAM-1 (15500), E-selectin ( 15100), PECAM-1 (15200 ), MHC class II ( 1525), and mouse IgG not given before biopsy. The patients with primary renal disease did not have any immunosuppressive treatment at (15100) at room temperature. After rinsing, sections were incubated with an alkaline-phosphatase-labelled secondary the time of biopsy, with the exception of two patients with systemic lupus erythematosus (SLE) and two patients with goat anti-mouse antibody (1540) for 30 min and with the Table 1 . De novo expression of ICAM-1, VCAM-1 and E-selectin in primary renal diseases. The Table summarizes the results of 71 renal biopsies. Tissue specimens, which were defined as 'normal kidney', were derived from five patients with minimal glomerular changes and from the disease-free part of five tumour nephrectomies. E-selectin was never expressed in tubules and ICAM-1 was always present in the vasculature of normal and diseased kidneys, but was overexpressed in inflammatory diseases (see Results). In the patient with HSP, E-selectin was expressed in the glomerular tuft. Abbreviations: GN, glomerulonephritis; SLE, systemic lupus erythematosus; n, number of biopsies studied.
Histopathological diagnosis
Tubules Vasculature n APAAP-detection system for another 30 min. After repeating mesangial proliferative glomerulonephritis ( IgA-nephthe last two steps of the staining protocol (each for 10 min) ritis), but was detected in seven of nine cases of focal sections were developed with New Fuchsin substrate system, necrotizing glomerulonephritis (6 of 9 patients were Pweakly counterstained with Mayer's haematoxylin solution or C-ANCA positive), in the two patients with SLE and subsequently mounted on glycerol gelatin. Primary and ( Figure 2C ), in the patient with Henoch-Schoenlein secondary antibodies were diluted in 1% bovine serum purpura ( HSP), in one of three patients with haemo- to VCAM-1, E-selectin expression was weakly present in one biopsy from a patient with focal necrotizing
Results glomerulonephritis and in one biopsy with a diagnosis of SLE in a small vessel ( Figure 4C ). Vascular Expression of cell adhesion molecules in normal kidneys VCAM-1 expression correlated with the intensity of the inflammatory process ( Table 1 ) . In five patients In normal kidneys a strong and homogenous ex-MHC class II molecules were coexpressed with pression of PECAM-1 was found exclusively on endo-VCAM-1 in endothelia of large vessels ( Figure 2D ). thelial cells of glomerular and peritubular capillaries Glomerular expression of VCAM-1 was localized in ( Figure 1A ) and of larger vessels (data not shown). cellular crescents in rapid progressive glomerulo-ICAM-1 showed a similar distribution as PECAM-1, nephritis and in segmental lesions of the capillary tuft but was less strongly expressed and found predomi- (Figures 3A-C ) . Cellular crescents were observed in nantly in glomerular capillaries ( Figure 1B ) and large one of twelve biopsies with a diagnosis of mesangial vessels ( Figure 1C ). VCAM-1 was always detected on proliferative glomerulonephritis and in five of nine epithelial cells of Bowman's capsule ( Figure 1D ). biopsies from patients with focal necrotizing glom-E-selectin was not expressed in normal kidneys. MHC erulonephritis, where VCAM-1 was always expressed class II antigens were moderately expressed in peritubu-in a homogenous and strong pattern in the crescents, lar capillaries, weakly in glomerular endothelial cells, and in one case in the mesangial cells of the glomerulus. but not in larger vessels (data not shown).
Moreover VCAM-1 was localized in segmental lesions of destroyed capillary tufts ( Figure 3C ). The only Expression of cell adhesion molecules in primary renal glomerular expression of E-selectin occurred in the diseases patient with HSP, who died a few days after acute onset of disease from multiorgan failure ( Figure 3D ). Histopathologically inflammatory primary kidney diseases can be divided into diseases with a mainly
The expression of PECAM-1 in the renal vasculature was not aÂected by inflammatory kidney diseases. glomerular, tubulointerstitial, or vascular involvement of the renal parenchyma.
PECAM-1, however, was diminished in obliterated glomeruli with endothelial cell destruction, such as in Focal de novo expression of ICAM-1 and VCAM-1 in tubules occurred in various primary renal diseases amyloidosis, chronic glomerulonephritis or diabetic glomerulosclerosis ( Figure 4A ). ICAM-1 was overexand correlated with the severity of tissue damage or the intensity of acute inflammatory reactions pressed in glomeruli, peritubular capillaries and larger vessels in acute inflammatory processes, such as focal ( Figure 2A and 2B) . ICAM-1 was particularly localized in the brush-border of tubular cells, whereas necrotizing or postinfectious glomerulonephritis or autoimmune disorders ( Figure 4B ). VCAM-1 showed a cytoplasmic staining pattern or a predominant basolateral localization in tubules [11] . Details of the frequency of distribution in diÂerent Expression of cell adhesion molecules in renal allografts renal diseases are described in Table 1 . De novo tubular expression of VCAM-1 was more frequent and pro-During allograft rejection, the expression of PECAM-1 did not diÂer from normal kidneys (see Figure 1A) . In nounced than that of ICAM-1. Apart from acute tubular necrosis and chronic renal disease with tubular kidneys with moderate and severe allograft rejection (n=16), characterized by tubulitis and/or vasculitis damage, de novo expression of VCAM-1 was detected in acute interstitial nephritis with tubular infiltration [12] , ICAM-1 expression was diÂusely increased in glomerular cells and particularly upregulated in and acute glomerulonephritis, especially focal necrotizing glomerulonephritis and autoimmune dis-peritubular capillaries ( Figure 5A ) and larger vessels ( Figure 5B ). Overexpression of ICAM-1 in renal endoeases (e.g. P-ANCA positive vasculitis, Wegener's granulomatosis, or SLE ).
thelia was combined with a focal de novo expression of ICAM-1 on the apical surface of tubular cells in De novo expression of VCAM-1 in the renal vasculature (small vessels and occasionally peritubular five of sixteen cases. These changes correlated with the severity of allograft rejection with respect to both, capillaries) was associated with early stages of acute inflammatory glomerular disease with or without auto-cellular tissue infiltration and clinical course of the rejection episode. In chronic rejection, ICAM-1 upregimmune disorders. Vascular expression of VCAM-1 was not detected in acute tubular necrosis, interstitial ulation was less striking. In four cases of membranoproliferative glomerulonephritis of the renal allograft, nephritis, diabetic glomerulosclerosis, nephrosclerosis, amyloidosis, focal segmental glomerulosclerosis and ICAM-1 expression was not diÂerent from normal kidneys in the endothelium, but was expressed de novo VCAM-1. In some cases of chronic transplant rejection with arteriosclerosis, VCAM-1 was expressed in nonin the tubular brush-border in two of four biopsies.
In moderate and severe allograft rejection, VCAM-1 glomerular endothelial cells of small vessels (n=3/6 ) and single tubules. Occasionally, infiltrating leukocytes was found to be expressed de novo on tubular cells (n=8/16 ), peritubular capillaries (n=3/16 ) and small were VCAM-1-positive. In two of four cases of glomerulonephritis of the allograft VCAM-1 was focally vessels (n=3/16 ) in a focal pattern ( Figure 5C ). In contrast, glomerular endothelial cells never expressed expressed on tubules and in one case in a small vessel. E-selectin was found only as focal E-selectin staining pattern of adhesion molecules remained unchanged with the exception of weak focal tubular VCAM-1 in single endothelial cells of peritubular capillaries in expression in one case. severe allograft rejection (n=4/16 ). One of these patients had a recurrent HUS. De novo expression of E-selectin and VCAM-1 was associated with the most Discussion severe forms of allograft rejection resulting in subsequent transplant loss in 50% of these patients.
The expression of the adhesion molecules ICAM-1, VCAM-1, E-selectin, and PECAM-1 was studied in During acute tubular necrosis (n=5) the expression normal renal tissue, renal allografts and biopsies from the severity of renal allograft rejection and reflect the intensity of inflammation in acute glomerulonephritis, patients with primary renal disease by immunohistochemistry of frozen sections. The data indicate that particularly when associated with autoimmune diseases. In contrast, PECAM-1 expression was not aÂec-immunohistochemical assessment of the vascular and/or glomerular expression of ICAM-1, VCAM-1 ted by inflammatory processes, but reduced in obliterated glomeruli with endothelial cell destruction. and E-selectin may serve as a diagnostic parameter of Fig. 4 . Expression of the adhesion molecules PECAM-1 ( A), ICAM-1 ( B) and E-selectin (C ) in primary renal diseases. PECAM-1 is no longer expressed in obliterated glomeruli, as observed in advanced diabetic glomerulosclerosis (A). ICAM-1 is overexpressed in glomeruli of a patient with SLE ( B). E-selectin is expressed de novo in a renal artery of the same patient (C). Magnification: ×200 ( A, B) ; ×400 (C).
Tubular expression of cell adhesion molecules seems [11, [13] [14] [15] [16] , in situ hybridization [13 ] , electronmicroscopy [11] or in combination with cell culture to be a marker of extensive structural damage, due to inflammatory processes, acute tubular necrosis, or studies of renal tubular cells [16 ] . In most of the studies, vascular and tubular expression of VCAM-1 chronic kidney disease.
The expression of VCAM-1 [11, 13, 14] , or ICAM-1, and vascular expression of E-selectin, as well as upregulation of ICAM-1 was found. The intensity and VCAM-1 and E-selectin [15, 16 ] in renal allograft rejection has been examined by immunohistochemistry localization of the expression of the cell adhesion molecules, however, varied between the diÂerent invest-rejection episode, suggesting that the expression of adhesion molecules could serve as an additional diaigators depending on the antibodies used, the sample size of the investigated biopsies, and the selection of gnostic or prognostic marker for allograft rejection.
In vitro experiments have demonstrated that upregultissue specimens with respect to the severity of the rejection or the time after transplantation. In our ation or induction of adhesion molecules on endothelial or epithelial cells is dependent on the stimulation with patient population de novo expression of VCAM-1 and E-selectin, which was detectable in <25% of the 42 cytokines such as TNFa, IL-1 and IFNc [17] . Local overexpression of TNFa has been demonstrated transplant biopsies, correlated with the severity of the in kidney biopsies during allograft rejection [18] . VLA-4 positive macrophages and lymphocytes which in turn could increase local cytokine production [21 ] . Therefore upregulation of adhesion molecules in the tissue of rejecting kidneys seems to be a logical step in Whether VCAM-1 expression in segmental necrosis of the capillary tuft derived from endothelial cells or the cascade of inflammatory tissue reaction. The pathogenetic importance of the expression of adhesion mole-adjacent podocytes cannot be answered by immunohistochemistry, but could be investigated by electroncules, however, is not clearly understood. Adhesion molecules may mediate the infiltration process but may microscopy.
The increased tubular expression of ICAM-1 and also serve as a costimulatory signal for T-cell-receptor activation by antigen presenting cells. Current VCAM-1 in all forms of chronic renal disease might be the reason for or the consequence of chronic tubuloimmunosuppressive drugs do not seem to downregulate or to prevent cytokine-induced expression of adhesion interstitial infiltration in primary glomerular lesions, causing interstitial fibrosis and progression of renal molecules. Further clues to the definite role of adhesion molecules for transplant rejection will be obtained disease [28] .
Immunosuppression is the therapy of choice for from interventional studies with anti-adhesion molecules or oligonucleotides, such as ongoing clinical trials autoimmune diseases and rapid progressive glomerulonephritis [29 ] . In other forms of glomerulonephritis with anti-ICAM-1 or anti-LFA-1 in transplant patients [19, 20] . a significant therapeutical eÃcacy of immunosuppressants has not been proven [30] . In acute The expression of adhesion molecules in inflammatory primary renal diseases compared with non-inflammatory renal diseases overexpression of cell adhesion molecules in renal vasculature and glomeruli inflammatory renal diseases or biopsies without histopathological changes has been studied by only a could be an additional indicator for the probability of success of immunosuppressive therapy. few investigators, but with controversial results. Roy-Chaudhury et al.
[21] examined a large number
Whether therapies with anti-adhesion molecules are useful for the treatment of autoimmune disorders or of biopsies and described a coordinate upregulation of adhesion molecules closely linked to chronic histo-crescentic glomerulonephritis has to be tested in experimental models and, if successful, in clinical trials [31 ] . logical damage, irrespective of the primary diagnosis. In contrast to these data we and other groups [22] [23] [24] [25] Sequential histological evaluation during the course of the disease is not possible in patients, but would be found a strong correlation between the expression of VCAM-1 in tubuli, glomeruli and vasculature and the useful in animal models. Another target of immunosuppressive therapy could imply the regulation of diagnosis of acute necrotizing glomerulonephritis and autoimmune disease. Moreover we observed diÂerences transcription factors for genes encoding both cell adhesion molecules and cytokines, such as NF-kB, that is in the tubular versus vascular or glomerular expression of cell adhesion molecules in diÂerent renal diseases. upregulated in nephrotoxic nephritis, an animal model for autoimmune disease [32] . Whereas tubular expression of ICAM-1 and VCAM-1 was correlated with structural tubular damage and interstitial fibrosis, vascular and glomerular expression Acknowledgements. This work was supported by a grant from the of VCAM-1 and occasionally of E-selectin was strongly Deutsche Forschungsgemeinschaft ( DFG: Ha 1719/2-1 ) and by a grant from the Ulrich Gessler-Stiltung.
linked to acute severe inflammatory renal diseases, such as focal necrotizing glomerulonephritis with crescent formation and glomerulonephritis in autoimmune disorders.
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